← All indications
Child Development Disorders, Pervasive
Severe distortions in the development of many basic psychological functions that are not normal for any stage in development. These distortions are manifested in sustained social impairment, speech abnormalities, and peculiar motor movements.
Subtype terms (1)
More specific conditions that are subtypes of Child Development Disorders, Pervasive in the MeSH hierarchy.
- Autism Spectrum Disorder
157 drugs (84 approved, 73 experimental)
Drugs by status
Phase 4 trials (5)
Phase 3 trials (2)
Phase 1 trials (1)
Other trials (1)
Organizations
Organization Involved with Phase 4 Indications (17)
- National Institutes of Health (NIH)
- National Institute of Mental Health (NIMH)
- University of Pittsburgh
- Harvard University
- Duke University
- Emory University
- University of Washington
- Katholieke Universiteit Leuven
- Ohio State University
- University of Rochester
- Yale University
- University of California, Los Angeles
- University of North Carolina at Chapel Hill
- Washington University in St. Louis
- Massachusetts Institute of Technology
- Government of Singapore
- Demarest Lloyd Jr. Foundation
Organization Involved with Phase 3 Indications (20)
- Bristol-Myers Squibb
- Servier
- Roche
- Seaside Therapeutics, Inc.
- Otsuka
- Nobel Pharmaceuticals
- Indiana University
- Mclean Hospital
- University of Toronto
- University of Arkansas
- Columbia University
- Kurume University
- University of Cincinnati
- Vanderbilt University
- Department of Defense
- University of Sao Paulo
- University of Paris
- Autism Speaks
- Lundbeck
- Assistance Publique - Hôpitaux de Paris
Organization Involved with Phase 2 Indications (50)
- Forest Laboratories
- Bioelectron
- Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
- OptiNose AS
- PediaMed Pharmaceuticals
- The EMMES Corporation
- University of Arizona
- Arizona State University
- Guangzhou Medical University
- Hamamatsu University
- Hoosier Cancer Research Network
- Johns Hopkins University
- McMaster University
- Northwestern University
- Osaka University
- University of Louisville
- University of Oslo
- Stony Brook University
- Tel Aviv University
- University of California, Davis
- University of California, San Francisco
- University of Chicago
- University of Colorado, Denver
- Icahn School of Medicine at Mount Sinai
- GW Research
- University of Minnesota
- Jiao Tong University
- Red Oak Psychiatry
- Hebrew University
- Rush University
- +20 more
Organization Involved with Phase 1 Indications (10)
Organization Involved with Other Experimental Indications (11)